Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) EBIT: ₺33 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:EGEPO Nasmed Ozel Saglik Hizmetleri Ticaret AS IST:EGEPO
73 GF Score
Price ₺18.28
GF Value ₺8.41
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Nasmed Ozelglik Hizmetleri Ticaret AS EBIT?

Nasmed Ozelglik Hizmetleri Ticaret AS IST:EGEPO -2.45% 73 EBIT is ₺33 Mil as of Dec. 2025. GuruFocus rates IST:EGEPO with a GF Score™ of 73/100 and a GF Value™ of ₺8.41 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Nasmed Ozelglik Hizmetleri Ticaret AS's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was ₺7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was ₺33 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nasmed Ozelglik Hizmetleri Ticaret AS's annualized ROC % for the quarter that ended in Dec. 2025 was 4.09%. Nasmed Ozelglik Hizmetleri Ticaret AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 1.83%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nasmed Ozelglik Hizmetleri Ticaret AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 0.36%.


Nasmed Ozelglik Hizmetleri Ticaret AS  (IST:EGEPO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nasmed Ozelglik Hizmetleri Ticaret AS's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=78.124 * ( 1 - 0% )/( (1833.991 + 1988.97)/ 2 )
=78.124/1911.4805
=4.09 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2093.461 - 131.231 - ( 128.979 - max(0, 180.111 - 308.35+128.979))
=1833.991

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2309.289 - 158.344 - ( 165.265 - max(0, 202.149 - 364.124+165.265))
=1988.97

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Nasmed Ozelglik Hizmetleri Ticaret AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=29.708/( ( (1524.182 + max(1.31, 0)) + (1714.709 + max(-4.8329999999999, 0)) )/ 2 )
=29.708/( ( 1525.492 + 1714.709 )/ 2 )
=29.708/1620.1005
=1.83 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(147.788 + 10.232 + 19.24) - (131.231 + 0 + 44.719)
=1.31

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(162.122 + 10.04 + 23.183) - (158.344 + 0 + 41.834)
=-4.8329999999999

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nasmed Ozelglik Hizmetleri Ticaret AS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=32.881/9015.154
=0.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nasmed Ozelglik Hizmetleri Ticaret AS EBIT Related Terms


Nasmed Ozelglik Hizmetleri Ticaret AS EBIT Historical Data

* Premium members only.

The historical data trend for Nasmed Ozelglik Hizmetleri Ticaret AS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nasmed Ozelglik Hizmetleri Ticaret AS EBIT Chart

Nasmed Ozelglik Hizmetleri Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial 39.59 24.17 -124.16 171.04 -7.21

Nasmed Ozelglik Hizmetleri Ticaret AS Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.16 18.04 3.78 3.64 7.43

IST:EGEPO vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Nasmed Ozelglik Hizmetleri Ticaret AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nasmed Ozelglik Hizmetleri Ticaret AS EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nasmed Ozelglik Hizmetleri Ticaret AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nasmed Ozelglik Hizmetleri Ticaret AS's EV-to-EBIT falls into.


IST:EGEPO
73GF Score
Nasmed Ozel Saglik Hizmetleri Ticaret AS IST:EGEPO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nasmed Ozelglik Hizmetleri Ticaret AS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₺33 Mil mean?
Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) has a EBIT of ₺33 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nasmed Ozelglik Hizmetleri Ticaret AS.
Is Nasmed Ozelglik Hizmetleri Ticaret AS's EBIT too high?
Nasmed Ozelglik Hizmetleri Ticaret AS's current EBIT is ₺33 Mil. Overall, Nasmed Ozelglik Hizmetleri Ticaret AS has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nasmed Ozelglik Hizmetleri Ticaret AS's EBIT compare to HCA and THC?
Nasmed Ozelglik Hizmetleri Ticaret AS's EBIT of ₺33 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nasmed Ozelglik Hizmetleri Ticaret AS. Nasmed Ozelglik Hizmetleri Ticaret AS's current EBIT is ₺33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nasmed Ozelglik Hizmetleri Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺8.41, compared to a current price of ₺18.28 — trading 117.4% above its estimated fair value. The current EBIT is ₺33 Mil. Nasmed Ozelglik Hizmetleri Ticaret AS's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO), the current EBIT is ₺33 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Overvalued in 2026?

Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS stock appears to be overvalued. The current stock price of ₺18.28 is trading 117.4% above its estimated GF Value™ of ₺8.41. GuruFocus considers Nasmed Ozelglik Hizmetleri Ticaret AS to be Significantly Overvalued.

Key valuation signals for IST:EGEPO:

  • EBIT: ₺33 Mil
  • GF Value™: ₺8.41 vs. price of ₺18.28 (117.4% above fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the IST:EGEPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nasmed Ozelglik Hizmetleri Ticaret AS Business Description

Address Iller Bankasi Halide Edip Adivar Bulvar, 507. Sk. No:3, Izmir, TUR, 35270
Nasmed Ozel Saglik Hizmetleri Ticaret AS provides quality healthcare services. It arranges consultations, travel planning, accommodation, translation, and other relevant services for its patients 24/7.
73GF Score

Get the complete analysis for IST:EGEPO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺18.28
Price
₺8.41
GF Value